PRKAA1 and diabetes mellitus: The activation of hepatic AMP-activated protein kinase (AMPK), which acts as a ‘metabolic master switch’, alleviates diabetes symptoms by reducing glycogen synthesis, increasing glycolysis, and promoting glucose absorption in surrounding tissues (Viollet et al., 2006).